- Investing Ideas
- South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
SK Biopharmaceuticals
Market Cap: ₩6.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩86,500.00
7D
-1.3%
1Y
-11.0%
Samsung BiologicsLtd
Market Cap: ₩72.8t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,574,000.00
7D
0.6%
1Y
0.7%